Evaluating the effects of hypoglossal nerve stimulation on metabolism in sleep apnea patients
Official title: Cardiometabolic Risk Effects of Short-term Cessation of Effective Neurostimulation Therapy in OSA
Run by Columbia University · NCT06720545 · Data updated 2026-11-12
This study is testing if a therapy that stimulates a nerve in the tongue can help people with sleep apnea improve their metabolism and reduce health risks.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Columbia University Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | January 5, 2025 |
| Main results expected | January 2027 |
| Study ends | January 2028 |
| Registry record updated | July 10, 2025 |
| Trial ID | NCT06720545 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking adults aged 18 and older who have been using HGNS therapy effectively for at least three months.
✕Probably not a fit
Patients with chronic opiate use, pregnancy, or severe excessive daytime sleepiness may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the impact of hypoglossal nerve stimulation (HGNS) therapy on metabolic outcomes and inflammation in patients with obstructive sleep apnea (OSA). Participants will have been using HGNS for at least three months and will undergo assessments to determine if the therapy reduces their risk of medical complications associated with OSA. The study aims to provide insights into how HGNS may influence metabolic health in this patient population.
Why it matters
Potential benefit: If successful, this study could lead to improved metabolic health and reduced medical risks for patients with obstructive sleep apnea.
How similar studies have gone: While hypoglossal nerve stimulation has been studied, this specific focus on metabolic outcomes is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * English-speaking adults (18+ years) who have met surgical efficacy criteria with HGNS, as defined by at least a 50% reduction in apnea-hypopnea index (AHI) to \<20 (with hypopneas defined by 4% oxyhemoglobin desaturations) * Have been using HGNS therapy for at least 3 months and used HGNS for \>20 hours/week during the past 4 weeks * Were not using any OSA therapy for at least one month prior to HGNS activation or have had a one-month period of untreated OSA after HGNS activation Exclusion Criteria: * Chronic use of opiate medications, illicit drugs, or alcohol dependency * Women who are pregnant or planning to become pregnant * Shift workers, heavy machinery operators, or commercial drivers * History of severe excessive daytime sleepiness (Epworth Sleepiness Scale score \>16 at time of screening or prior to HGNS), motor vehicle accidents or near-miss incidents due to drowsy driving within the year prior to enrollment * Significant cardiopulmonary (such as home oxygen requirement), liver, renal, or oncologic disease; neurodegenerative disease; active or recent history of an eating disorder (within the last 5 years) * Inability to provide informed consent
Where it's running
-
Columbia University Medical Center
New York, New York, United States Recruiting
Study contacts
- Study coordinator: Otolaryngology Research Group
- Email: otosleepresearch@cumc.columbia.edu
- Phone: 646-317-3252
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multimodal Deep Learning to Predict Sleep Apnea Severity from SpO2 and Ballistocardiography
Researchers are testing a smart-mattress-based method that uses SpO2 and ballistocardiography data to predict sleep apnea severity in adults undergoing overnight sleep study.
-
Nightly wearable monitoring with at-home submental electrical stimulation for sleep apnea
This pilot test checks whether wearing a ring sensor at night and doing a 4-week at-home submental electrical stimulation is feasible for adults with obstructive sleep apnea and looks at changes in sleep metrics.
-
Functional capacity and muscle function in adults with obstructive sleep apnea
This study tests how obstructive sleep apnea affects respiratory and peripheral muscle strength, endurance, and upper‑extremity function compared with healthy adults.
-
Transcutaneous Electrical Stimulation for Obstructive Sleep Apnea
This study tests whether applying gentle electrical stimulation to the throat muscles at night can reduce sleep apnea severity in adults with obstructive sleep apnea.
-
Physical activity habits and sleep/ breathing in obstructive sleep apnea
This study tests whether daily physical activity habits affect sleep quality and breathing measurements in people with obstructive sleep apnea who are on CPAP therapy.
-
CES-EES score and a wearable ring for diagnosing obstructive sleep apnea
This study tests whether the CES-EES clinical score and the Belun Ring wearable can accurately diagnose obstructive sleep apnea without in-lab polysomnography in adults referred for suspected OSA.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.